Azioni Alexion Pharmaceuticals, Inc.
Azioni
ALXN
US0153511094
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01/08/21 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+27,97% | 672 Mrd | |
+23,58% | 550 Mrd | |
-7,02% | 351 Mrd | |
+14,85% | 317 Mrd | |
+6,25% | 292 Mrd | |
+2,96% | 211 Mrd | |
-0,41% | 203 Mrd | |
-10,02% | 194 Mrd | |
-11,81% | 144 Mrd |